
The short answer on when OATS is the right call
The question most patients arrive with is a practical one: is bone-plug surgery actually the right option for my ankle, or is there something simpler — or more extensive — that fits better?
For the right lesion and the right patient, OATS is the answer. Three criteria need to line up. First, the defect should be focal and well-contained on the talar dome — small to medium in size, where autograft plugs harvested from the patient's own knee can realistically fill the area. Second, the subchondral bone beneath the cartilage should be involved: cyst formation, fragmentation, or an osteochondritis dissecans (OCD)-related fracture. When the bone base is compromised, a cartilage-only repair leaves nothing solid to anchor to — OATS restores both layers simultaneously. Third, the patient profile should fit a single-stage, joint-preserving approach: typically young to middle-aged, sports-active, and not yet a candidate for joint replacement.
Where those three gates are met, OATS offers a durable biological repair that microfracture — which produces fibrocartilage rather than true hyaline tissue — cannot match over the long term. Where they are not met, the pathway shifts: very small or superficial lesions may suit less invasive approaches first, whilst defects that exceed realistic autograft harvest capacity point towards osteochondral allograft (OCA) instead.
What the procedure involves
During an OATS procedure, the surgeon takes one or more small cylindrical plugs of healthy tissue from a low-weight-bearing zone of the patient's own knee — typically the periphery of the femoral condyle — and transfers them into the prepared defect on the talar dome of the ankle. Each plug is a composite unit: full-thickness hyaline cartilage sitting atop a column of subchondral bone. Once press-fitted into the recipient site, the bone portion gradually osseointegrates with the surrounding host bone, locking the transplanted cartilage surface securely in place.
When a single defect is too wide or too irregular in shape to be filled cleanly by one plug, the surgeon switches to a mosaicplasty configuration — several smaller-diameter plugs tiled together across the defect floor. The result resembles a mosaic of tissue cores seated flush with the surrounding native cartilage. Which configuration is used depends on the exact dimensions and geometry of the lesion; that selection logic is covered in the next section.
A practical feature of both approaches is that harvest and transfer happen in a single operative session. There is no need to send tissue to a laboratory, culture cells, or schedule a return visit for implantation. Because the graft comes from the patient's own body, there is also no donor tissue to procure, no tissue-bank processing, and no human-tissue regulatory framework to navigate — which simplifies the patient pathway considerably.
Access to the talar dome is achieved arthroscopically in many cases, using small ankle portals. Posterolateral lesions, or defects requiring a larger graft footprint, may need a small supplementary incision or a temporary malleolar window to allow the surgeon adequate angle and depth to seat the plugs correctly. Theatre time is typically in the range of 90 to 120 minutes.
How defect size and shape decide between single-plug and mosaic
Defect size is where the decision tree branches most clearly. For a focal, well-contained lesion measuring roughly 1–2 cm² on the talar dome, a single cylindrical plug provides adequate coverage and a clean cartilage-to-cartilage margin with the surrounding native tissue — the classic single-plug OATS indication.
When the defect is wider, or where its footprint is irregular enough that one plug would leave meaningful gaps at the edges, the surgeon tiles several smaller-diameter cores across the floor in a mosaic arrangement. Mosaicplasty extends practical coverage to approximately 2–4 cm², matching the geometry of the lesion rather than forcing a single large bore through limited ankle anatomy.
Beyond the volume of autograft that can reasonably be taken from the knee without causing significant donor-site problems, a change in strategy is warranted. Osteochondral allograft (OCA) — donor-sourced tissue rather than the patient's own — becomes the appropriate next step for larger defects where autograft alone would fall short. Surgeons typically use these size ranges as a working guide; the precise boundary between mosaicplasty and OCA is a clinical judgement call based on defect geometry, harvest-site tolerance, and individual anatomy, not a single fixed threshold.
Containment is a parallel consideration. A lesion with well-defined, stable shoulders holds each plug firmly against the host bone wall. A defect that runs to the peripheral edge of the talar dome — uncontained on one side — introduces graft-seating challenges that may favour allograft regardless of the overall surface area.
Why the subchondral bone layer matters for repair choice
Osteochondritis dissecans — one of the most common causes of talar osteochondral lesions — does not injure the cartilage surface in isolation. In OCD, stress fractures develop within the subchondral bone beneath the talar dome; as those cracks propagate, the overlying cartilage loses its structural support and begins to fail as well. The result is a two-layer injury: both the bone foundation and the cartilage surface are compromised together.
Marrow-stimulation techniques such as microfracture address only the cartilage side of that equation. By breaching the subchondral plate with fine perforations, microfracture encourages the formation of fibrocartilage — a repair tissue that differs structurally from the native hyaline cartilage of a healthy joint surface. Fibrocartilage is softer and less resistant to repeated compressive loading; evidence suggests it tends to break down within two to three years of repair. A less-discussed consequence is that repeated perforation of the subchondral plate can damage its architecture, potentially limiting the options available for any subsequent procedure if the first repair fails.
OATS resolves both layers in a single step. The bone column within each plug occupies and structurally restores the defect floor; the native hyaline cartilage on top matches the mechanical properties of the surrounding joint surface. Articular cartilage has poor intrinsic regenerative capacity, which is why restoring the correct tissue type — rather than allowing fibrocartilage to fill the gap — matters for long-term durability. Where cyst formation has developed beneath the talar dome, a recognised feature of advanced OCD, the bone portion of the plug fills that void and restores structural continuity. Scaffold-only or cell-based techniques cannot achieve this without adding a separate bone-grafting step.
Ten-year comparative follow-up data (Gudas et al., 2012) supports the durability advantage of hyaline restoration over microfracture — a meaningful consideration for younger, active patients who need the repair to remain functional across decades of loading.
Donor site, recovery, and realistic expectations
Booking a talar OATS procedure means accepting a trade-off worth stating plainly. The autograft plugs come from the patient's own knee — typically a low-load zone of the medial or lateral trochlea — and most patients experience temporary knee discomfort at that harvest site in the weeks following surgery. This resolves in the majority of cases and is a known, manageable quantity, but donor-site morbidity is a real feature of the procedure, not a footnote. Where mosaicplasty is used, the harvest footprint at the knee increases proportionally — a factor worth discussing explicitly with any patient planning a high-demand return to sport.
Recovery follows a structured protocol. Weight-bearing is initially restricted and advances progressively as graft integration proceeds; physiotherapy is integral throughout. Return to full sport-level activity generally takes nine to twelve months, reflecting the time the bone component of each plug requires to osseointegrate with the host subchondral bed before the reconstructed surface can tolerate athletic loading demands.
The ten-year follow-up data from Gudas et al. (2012) — comparing OATS with microfracture in young, active patients — provides the most durable long-term anchor currently available. Functional outcomes held across a decade in a way that microfracture repairs did not, supporting OATS as a lasting intervention for focal osteochondral disease in this patient group.
Ankle-specific comparative data is thinner than the equivalent knee literature. Validated functional scoring such as AOFAS ratings and revision rates for talar OATS against OCA or cell-based alternatives are not yet comprehensively established in published series. For the patient making this decision, the biological rationale is sound and the structural results are supported — but individual outcome projections for an ankle lesion are best worked through with a specialist who can draw on current registry data and clinical experience alongside the published evidence.
Assessment and next steps
Taken together, the case for OATS at the talus rests on three converging factors: a focal, contained defect of small-to-medium area; subchondral involvement that makes a surface-only repair structurally insufficient; and a patient profile — typically active and committed to joint preservation — for whom restoring native hyaline cartilage offers a durable advantage over fibrocartilage fill. Where those three factors align, bone-plug transfer is a mechanically and biologically coherent choice.
Translating that framework into a surgical plan requires formal assessment. MRI with cartilage-specific sequencing establishes defect dimensions, subchondral status, and any cyst formation that might influence plug depth or configuration. Clinical history and activity goals help determine whether the donor-site trade-off and recovery timeline are appropriate for that individual. Lesion location on the talar dome is also part of the pre-operative picture: anteromedial and posterolateral defects differ in arthroscopic accessibility, with some posterolateral lesions requiring a malleolar osteotomy for adequate exposure — a factor that influences operative planning and the subsequent rehabilitation pathway.
At the London Cartilage Clinic, Professor Paul Y. F. Lee's specialist focus on osteochondral repair and joint-preservation surgery makes LCC the appropriate London referral point for patients with ankle OLTs being considered for bone-plug transfer. To arrange an assessment, visit londoncartilage.com.
Frequently Asked Questions
- OATS suits focal defects with subchondral bone involvement, small-to-medium size, and patients committed to joint preservation. London Cartilage Clinic can assess whether your lesion meets these criteria.
- OATS restores durable hyaline cartilage rather than fibrocartilage, supported by ten-year evidence in active patients. Your specialist at London Cartilage Clinic can advise which suits your lesion.
- Single plugs handle 1–2 cm² defects; mosaic patterns extend to about 2–4 cm². London Cartilage Clinic assesses sizing and can recommend allograft for larger lesions if needed.
- Surgeons harvest from low-load knee zones; most patients experience temporary discomfort at the harvest site, which resolves. London Cartilage Clinic discusses donor-site trade-offs before surgery.
- Full sport return generally takes nine to twelve months as the bone component integrates. Recovery follows a structured protocol—London Cartilage Clinic guides your rehabilitation pathway.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].


